Illumina Inc. (ILMN) 10-K Red Flags
Risk signals extracted deterministically from Illumina Inc.’s SEC 10-K/10-Q XBRL filings — no LLM, every finding cites the underlying data.
Detected red flags (11)
- Gross margin compression: Gross margin contracted +3.9%pp (from 64.8% to 60.9%). This may reflect input cost inflation, pricing pressure, or product mix shift toward lower-margin segments.
- Deferred revenue growing — future revenue visibility: Deferred revenue grew +25.2% to $121.0M, providing forward revenue visibility. This is a positive leading indicator for subscription or contract-based businesses.
- Endogenous analysis: 1 positive signal(s) versus 1 risk signal(s). The filing exhibits more constructive indicators than concerns, though individual risk factors should still be monitored.
- 4 new XBRL disclosure(s) in latest filing — expanding reporting scope.
- 20 disclosure(s) dropped from prior year — reduced reporting granularity.
- Revenue declined **+1.7%** YoY to $4.50B.
- Net margin at **-25.78%** (contracting ▼).
- Market cap $28.55B at $188.68 per share.
- FCF DCF intrinsic value ≈ $34.11 → implied downside +81.9%.
- Latest annual report (10-K) filed Feb 12, 2026.
- Latest quarterly report (10-Q) filed May 4, 2026.
Filings & ownership
- Latest annual report (10-K) filed Feb 12, 2026.
- Latest quarterly report (10-Q) filed May 4, 2026.
- 13 recent 8-K material-event filings in the index.
- Recent insider Form 4s: 0 buy vs 9 sell transactions — net selling $365.1K.
Full ILMN analyst report
Valuation (DCF & Graham), technicals, macro exposure, risk scorecard and 13F/13D ownership.
View full report →Not investment advice. FilingSight is an automated analytical research tool, not a registered investment advisor. Ratings and scores are quantitative analytical classifications, not buy or sell recommendations. Nothing here is personalized to your circumstances. Investing involves risk of loss — consult a licensed professional. See full disclosures.